1. New inhibitors of chorismate synthase present antifungal activity against Paracoccidioides brasiliensis .
- Author
-
Bueno PS, Rodrigues-Vendramini FA, Toplak M, Macheroux P, Kioshima ÉS, and Seixas FA
- Subjects
- Amino Acid Sequence, Amphotericin B pharmacology, Animals, Antifungal Agents chemistry, Antifungal Agents metabolism, Candida albicans enzymology, Chlorocebus aethiops, Drug Synergism, Fungal Proteins chemistry, Fungal Proteins metabolism, HeLa Cells, Humans, Inhibitory Concentration 50, Microbial Sensitivity Tests, Molecular Docking Simulation, Molecular Structure, Paracoccidioides enzymology, Phosphorus-Oxygen Lyases chemistry, Phosphorus-Oxygen Lyases metabolism, Protein Binding, Vero Cells, Antifungal Agents pharmacology, Fungal Proteins antagonists & inhibitors, Paracoccidioides drug effects, Phosphorus-Oxygen Lyases antagonists & inhibitors
- Abstract
Aim: A structural model of chorismate synthase (CS) from the pathogenic fungus Candida albicans was used for virtual screening simulations. Methods: Docking, molecular dynamics, cell growth inhibition and protein binding assays were used for search and validation. Results: Two molecules termed CS8 and CaCS02 were identified. Further studies of the minimal inhibitory concentration demonstrated fungicidal activity against Paracoccidioides brasiliensis with a minimal inhibitory concentration and minimal fungicidal concentration of 512 and 32 μg·ml
-1 for CS8 and CaCS02, respectively. In addition, CaCS02 showed a strong synergistic effect in combination with amphotericin B without cytotoxic effects. In vitro studies using recombinant CS from P. brasiliensis showed IC50 of 29 μM for CaCS02 supporting our interpretation that inhibition of CS causes the observed fungicidal activity.- Published
- 2019
- Full Text
- View/download PDF